SCHEDULE 13G/A: BlackRock, Inc. Discloses 8.3% Stake in Agilent Technologies Inc.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 8.3% of Agilent Technologies Inc.'s common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 23,626,346 shares of Agilent Technologies Inc. common stock.
• This represents 8.3% of the total outstanding common stock of Agilent Technologies Inc.
• The filing date for this Schedule 13G Amendment No. 17 was April 17, 2025, with the event date being March 31, 2025.
• BlackRock, Inc. holds sole voting power over 20,789,200 shares and sole dispositive power over all 23,626,346 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• Various BlackRock subsidiaries are involved in the beneficial ownership, with some individually owning 5% or greater of the outstanding shares.

Sentiment

Score: 7

Explanation: The filing is a standard regulatory disclosure of a significant passive ownership stake by a major institutional investor, BlackRock, in Agilent Technologies. It indicates continued confidence from a large asset manager without suggesting any negative or activist intent. This is generally a neutral to slightly positive signal as it confirms institutional interest.

Positives

• BlackRock, a major institutional investor, maintains a significant stake (8.3%) in Agilent Technologies, indicating continued confidence.
• The holding is for investment purposes in the ordinary course of business, not for activist intentions, suggesting stability in the ownership structure.

Future Outlook

This Schedule 13G filing does not contain forward-looking statements or guidance regarding Agilent Technologies Inc.'s future performance or BlackRock's investment strategy beyond the current ownership disclosure.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

This filing reflects a routine disclosure of a significant passive ownership stake by a major asset manager, BlackRock, in Agilent Technologies, a company operating in the life sciences, diagnostics, and applied chemical markets. Such large institutional holdings are common for established companies in these sectors, indicating their inclusion in broad market indices and investment portfolios.

Comparison to Industry Standards

• As a Schedule 13G filing, this document primarily serves as a regulatory disclosure of passive ownership by a large institutional investor. It does not provide performance metrics for direct comparison to industry peers or benchmarks.
• BlackRock's 8.3% stake is a substantial holding for an institutional investor in a company of Agilent's size, aligning with typical portfolio allocations for diversified asset managers.

Management Changes

Corporate Governance

Stakeholder Impact

• This filing primarily impacts shareholders by providing transparency on a significant institutional ownership stake. It confirms BlackRock's continued investment in Agilent Technologies, which may be viewed positively by other investors. There is no direct impact on employees, customers, suppliers, or creditors mentioned.

Next Steps

• No specific future actions or milestones for Agilent Technologies Inc. are mentioned in this ownership disclosure filing.

Key Dates

Keywords

Agilent Technologies Inc., BlackRock Inc., Schedule 13G, Common Stock, Institutional Ownership, Beneficial Ownership, SEC Filing, Investment Management, Healthcare Technology, Life Sciences